General Resonance, Inc. – Havre de Grace, Maryland – www.generalresonance.com
General Resonance is applying its proprietary resonance technology to a wide variety of healthcare and energy product opportunities. Current areas of product focus include materials, energy, and data storage.

Merrimack Pharmaceuticals – Cambridge, Mass. – www.merrimackpharma.com
Merrimack Pharamaceuticals has emerged as a leader in personalized medicine. The company has a pipeline of several targeted anti-body-based cancer therapeutics, combined with predictive medicine diagnostic tests. These novel drug/diagnostic combinations are derived from Merrimack’s proprietary Network Biology drug development platform.

Numira BioSciences – Salt Lake City, Utah. – www.numirabio.com
Numira BioSciences has developed a novel software/hardware product offering that facilitates “virtual histology.” This process, for the first time, enables advanced biological tissue analysis that leaves research animals alive and intact, allowing researchers to conduct multiple studies on the same population.

Silver Creek Pharmaceuticals – San Francisco, Calif.
Silver Creek Pharmaceuticals utilizes its unique “Targeted Smart Growth Factors” technology to stimulate stem cell-based regeneration of cardiovascular tissues after a cardiac infarction. The Smart Growth Factors are delivered to the site where stem cell regeneration is desired by proprietary targeted antibodies.